Correlation Between Mereo BioPharma and Zura Bio
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Zura Bio Limited, you can compare the effects of market volatilities on Mereo BioPharma and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Zura Bio.
Diversification Opportunities for Mereo BioPharma and Zura Bio
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mereo and Zura is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Zura Bio go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Zura Bio
Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 0.7 times more return on investment than Zura Bio. However, Mereo BioPharma Group is 1.43 times less risky than Zura Bio. It trades about -0.08 of its potential returns per unit of risk. Zura Bio Limited is currently generating about -0.07 per unit of risk. If you would invest 443.00 in Mereo BioPharma Group on August 31, 2024 and sell it today you would lose (87.00) from holding Mereo BioPharma Group or give up 19.64% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Mereo BioPharma Group vs. Zura Bio Limited
Performance |
Timeline |
Mereo BioPharma Group |
Zura Bio Limited |
Mereo BioPharma and Zura Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mereo BioPharma and Zura Bio
The main advantage of trading using opposite Mereo BioPharma and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Zura Bio vs. US Global Investors | Zura Bio vs. Coursera | Zura Bio vs. Artisan Partners Asset | Zura Bio vs. Ihuman Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Commodity Directory Find actively traded commodities issued by global exchanges |